Cell-Free DNA (cfDNA) Testing Market Set for Explosive Growth rate CAGR of 26.2% by 2027 Know More with Emergen Research
The increasing demand for non-invasive testing methodologies and rising chronic disease incidence are driving the demand for the market.
VANCOUER, BC, CANADA, July 28, 2022 /EINPresswire.com/ -- The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period.
The Global Cell-Free Dna Testing Market report presents comprehensive information covering insightful data for businesses and investors for the time period of 2020-2027 .The globally-disrupting incidence has impacted nearly every aspect of this business domain. However, the latest study expounds on the present market scenario and forecasts the pandemicโs aftermath, with respect to this industry. Furthermore, the major aspects of the market have been discussed in the report, with expert opinions on the current status of the market.
๐๐๐ฒ ๐๐๐ฅ๐ฅ-๐ ๐ซ๐๐ ๐๐ง๐ ๐ญ๐๐ฌ๐ญ๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฉ๐๐ซ๐ญ๐ข๐๐ข๐ฉ๐๐ง๐ญ๐ฌ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others.
๐๐๐ญ ๐๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฅ๐ฅ-๐ ๐ซ๐๐ ๐๐ง๐ ๐ญ๐๐ฌ๐ญ๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐๐๐: https://www.emergenresearch.com/request-sample/156
North America is accounted for the largest market with a share of 33.6% in 2019, owing to the increasing chronic diseases and pregnancy problems in this region due to the changes in lifestyles of the population. Besides, the adoption of advanced technology in hospitals is also expected to boost the market shortly.
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
Cell-Free DNA (cfDNA) Testing Market Size โ USD 3.80 billion in 2019, Market Growth - CAGR of 26.2%, Market Trends โ The rise in the use of Cell-Free DNA (cfDNA) to treat chromosomal disorders. The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research.
๐๐๐ฒ ๐ข๐ง๐๐ฅ๐ฎ๐ฌ๐ข๐จ๐ง๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฅ๐ฅ-๐ ๐ซ๐๐ ๐๐ง๐ ๐ญ๐๐ฌ๐ญ๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:
COVID-19 effects on growth figures.
Statistical analysis pertaining to market size, sales volume, and overall industry revenue.
Organized mentions of major market trends.
Growth opportunities.
Figures showcasing market growth rate.
Advantages and disadvantages of direct and indirect sales channels.
Insights regarding traders, distributors, and dealers present in the industry.
๐๐จ๐ฆ๐ ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ :
In August 2019, Agilent Technologies Inc. announced the acquisition of a leading manufacturer of innovative healthcare equipment, BioTek Instruments, Inc. This acquisition will expand Agilentโs product portfolio and its presence in North America.
Cell-free fetal DNA is a non-invasive procedure and therefore does not pose a health risk of CVS (chorionic villus sampling) or amniocentesis, like pain and any slight chance of infection. Due to these benefits, the cell-free fetal DNA segment held the largest market share of 48.8% in the Cell-Free DNA (cfDNA) testing market, in 2019.
The MPSS technology segment is anticipated to dominate the global market with a CAGR of 26.7%, owing to the advantage of producing a measurable profile of gene expression in cells or tissues.
The gynecology segment is anticipated to lead the market during the forecasted period, as the cell-free DNA approach is being used to detect genetic issues of baby and to diagnose pregnancy complications such as pregnancy loss.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง, ๐๐๐, ๐๐๐๐ฅ๐ ๐จ๐ ๐ ๐ข๐ ๐ฎ๐ซ๐, ๐๐ก๐๐ซ๐ญ, ๐๐ญ๐. @ https://www.emergenresearch.com/industry-report/cell-free-dna-market
The study on the Global Cell-Free Dna Testing Market is the latest report covering the impact analysis of the currently ongoing COVID-19 pandemic. The pandemic has directly affected the market by causing disruptions in the global supply chains and indirectly by inducing financial difficulties. The Cell-Free Dna Testing Market has witnessed dynamic changes in trends and demands owing to the ongoing COVID-19 pandemic.
๐๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐ข๐ง๐ญ๐จ ๐๐จ๐ฎ๐ซ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ;
By Type : Cell-free fetal DNA (NIPT) , Circulating tumor DNA, Donor-derived cell-free DNA
By Technology : MPSS, t-MPS, SNP, Others
By Application Outlook : Transplantation, Gynecology, Oncology
By Regions : North America, Europe, Asia Pacific, Latin America, MEA
!!! ๐๐ข๐ฆ๐ข๐ญ๐๐ ๐๐ข๐ฆ๐ ๐๐๐๐๐๐๐๐ ๐๐ฏ๐๐ข๐ฅ๐๐๐ฅ๐!!! ๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐๐จ๐ฉ๐ฒ ๐๐ญ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ๐๐ ๐๐ซ๐ข๐๐ @ https://www.emergenresearch.com/request-discount/156
๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐๐ฅ๐ฅ๐ฒ, ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฌ๐ญ๐ฎ๐๐ข๐๐ฌ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ, ๐๐จ๐๐ฎ๐ฌ๐๐ฌ ๐จ๐ง ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ ๐ฌ๐๐ฅ๐๐ฌ, ๐ฏ๐๐ฅ๐ฎ๐, ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ก๐๐ซ๐ ๐๐ง๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐ข๐ง ๐ญ๐ก๐๐ฌ๐ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ, ๐๐จ๐ฏ๐๐ซ๐ข๐ง๐ :
United States
Europe
China
Japan
Southeast Asia
India
๐๐ ๐๐๐ง ๐๐ฅ๐ฌ๐จ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐ฌ๐๐ฉ๐๐ซ๐๐ญ๐ ๐ซ๐๐ ๐ข๐จ๐ง๐๐ฅ ๐จ๐ซ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐ฅ๐๐ฏ๐๐ฅ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ, ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
๐๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฌ๐ก๐๐ซ๐๐ฌ ๐ค๐๐ฒ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง:
Current market size
Market forecast
Market opportunities
Key drivers and restraints
Regulatory scenario
Industry trend
New product approvals/launch
Promotion and marketing initiatives
Pricing analysis
Competitive landscape
Leading Cell-Free dna testing market Players data , click @
Some of the key questions answered in this report:
What is the size of the overall Cell-Free dna testing market and its segments?
What are the key segments and sub-segments in the market?
What are the key drivers, restraints, opportunities and challenges of the Cell-Free dna testing market and how they are expected to impact the market?
What are the attractive investment opportunities within the Cell-Free dna testing market ?
What is the Cell-Free dna testing market size at the regional and country-level?
Who are the key market players and their key competitors?
What are the strategies for growth adopted by the key players in Cell-Free dna testing market ?
TO Check Our Other Blogs @
industrial fabric market
https://www.emergenresearch.com/industry-report/industrial-fabric-market
aircraft engine market
https://www.emergenresearch.com/industry-report/aircraft-engine-market
automotive smart tire market
https://www.emergenresearch.com/industry-report/automotive-smart-tire-market
hypersonic technology market
https://www.emergenresearch.com/industry-report/hypersonic-technology-market
virtual reality in medical market
https://www.emergenresearch.com/industry-report/virtual-reality-in-medical-market
military displays market
https://www.emergenresearch.com/industry-report/military-displays-market
electric vehicle take off and landing aircraft market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Thank you for reading our report. For further details or to inquire about customization, please let us know. We will offer you the report as per your needs.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.